Celltech Group, Lonza Group deal

Lonza division Lonza Biotec (Visp, Switzerland) will manufacture for CCH PEGylated antibody fragment-based compounds. CCH's

Read the full 157 word article

How to gain access

Continue reading with a
two-week free trial.